Literature DB >> 1139228

Editorial: New prospects in renal hypertension.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1139228      PMCID: PMC1673650          DOI: 10.1136/bmj.3.5975.59

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  7 in total

1.  Radioimmunoassay and pharmacokinetics of saralasin in the rat and hypertensive patients.

Authors:  W A Pettinger; K Keeton; K Tanaka
Journal:  Clin Pharmacol Ther       Date:  1975-02       Impact factor: 6.875

2.  THE ANGIOTENSIN-INFUSION TEST. A NEW APPROACH TO THE DIFFERENTIAL DIAGNOSIS OF RENOVASCULAR HYPERTENSION.

Authors:  N M KAPLAN; J G SILAH
Journal:  N Engl J Med       Date:  1964-09-10       Impact factor: 91.245

3.  Role of the pressor action of angiotensin II in experimental hypertension.

Authors:  D T Pals; F D Masucci; G S Denning; F Sipos; D C Fessler
Journal:  Circ Res       Date:  1971-12       Impact factor: 17.367

4.  Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis.

Authors:  M A Ondetti; N J Williams; E F Sabo; J Pluscec; E R Weaver; O Kocy
Journal:  Biochemistry       Date:  1971-10-26       Impact factor: 3.162

5.  An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients.

Authors:  H Gavras; H R Brunner; J H Laragh; J E Sealey; I Gavras; R A Vukovich
Journal:  N Engl J Med       Date:  1974-10-17       Impact factor: 91.245

6.  Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure.

Authors:  H R Brunner; H Gavras; J H Laragh
Journal:  Lancet       Date:  1973-11-10       Impact factor: 79.321

7.  Use of an angiotensin II antagonist (saralasin) in the recognition of "angiotensinogenic" hypertension;.

Authors:  D H Streeten; G H Anderson; J M Freiberg; T G Dalakos
Journal:  N Engl J Med       Date:  1975-03-27       Impact factor: 91.245

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.